The emergence of antibiotic resistance poses a significant challenge to modern medicine and global healthcare systems. Infections caused by resistant pathogens now result in higher morbidity and mortality rates, longer hospital stays, and increased treatment costs, placing a greater burden on healthcare resources. According to the 2019 U.S. Center For Disease Control (CDC) report, antibiotic resistance in the United States has been on the rise, with 2.8 million infections and more than 35,000 deaths annually. Hence, these trends highlight the pressing need for new antimicrobial agents that are less prone to resistance than conventional antibiotics.